312 related articles for article (PubMed ID: 26552849)
21. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
[TBL] [Abstract][Full Text] [Related]
22. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.
Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z
Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
24. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
[TBL] [Abstract][Full Text] [Related]
25. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
26. pH-Responsive Poly(ethylene glycol)/Poly(L-lactide) Supramolecular Micelles Based on Host-Guest Interaction.
Zhang Z; Lv Q; Gao X; Chen L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2015 Apr; 7(16):8404-11. PubMed ID: 25856564
[TBL] [Abstract][Full Text] [Related]
27. Reductive responsive micelle overcoming multidrug resistance of breast cancer by co-delivery of DOX and specific antibiotic.
Cui Y; Yang Y; Ma M; Xu Y; Sui J; Li H; Liang J; Sun Y; Fan Y; Zhang X
J Mater Chem B; 2019 Oct; 7(40):6075-6086. PubMed ID: 31389470
[TBL] [Abstract][Full Text] [Related]
28. Reduction-Degradable Polymeric Micelles Decorated with PArg for Improving Anticancer Drug Delivery Efficacy.
Cui Y; Sui J; He M; Xu Z; Sun Y; Liang J; Fan Y; Zhang X
ACS Appl Mater Interfaces; 2016 Jan; 8(3):2193-203. PubMed ID: 26720795
[TBL] [Abstract][Full Text] [Related]
29. Redox-Activatable ATP-Depleting Micelles with Dual Modulation Characteristics for Multidrug-Resistant Cancer Therapy.
Wang H; Li Y; Zhang M; Wu D; Shen Y; Tang G; Ping Y
Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28152267
[TBL] [Abstract][Full Text] [Related]
30. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
[TBL] [Abstract][Full Text] [Related]
31. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
32. Fully glutathione degradable waterborne polyurethane nanocarriers: Preparation, redox-sensitivity, and triggered intracellular drug release.
Omrani I; Babanejad N; Shendi HK; Nabid MR
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):607-616. PubMed ID: 27770933
[TBL] [Abstract][Full Text] [Related]
33. Micellization of antineoplastic agent to significantly upregulate efficacy and security.
Li C; Xu W; Ding J; Zhang Y; Wang J; Zhuang X; Chen X
Macromol Biosci; 2015 Mar; 15(3):328-41. PubMed ID: 25380513
[TBL] [Abstract][Full Text] [Related]
34. Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
Qi Y; Qin X; Yang C; Wu T; Qiao Q; Song Q; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1005-1016. PubMed ID: 29397749
[TBL] [Abstract][Full Text] [Related]
35. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
[TBL] [Abstract][Full Text] [Related]
36. Redox-responsive polyanhydride micelles for cancer therapy.
Wang J; Yang G; Guo X; Tang Z; Zhong Z; Zhou S
Biomaterials; 2014 Mar; 35(9):3080-90. PubMed ID: 24388799
[TBL] [Abstract][Full Text] [Related]
37. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
38. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
39. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
[TBL] [Abstract][Full Text] [Related]
40. Coencapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in vitro and in vivo.
Cao X; Luo J; Gong T; Zhang ZR; Sun X; Fu Y
Mol Pharm; 2015 Jan; 12(1):274-86. PubMed ID: 25469833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
